Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 25;9(4):793-796.
doi: 10.1182/bloodadvances.2024014590.

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm

Sabine Khalife-Hachem  1 , Arnaud Pages  2   3 , Elie Akoury  1 , Sarah Bonnet  4 , Rudy Birsen  5 , Clémence Busquet  6 , Adrien Contejean  7 , Alina Danu  1 , Stéphane de Botton  1 , Marie de Charette  8 , Pierre Yves Dumas  9 , Arnaud Jaccard  5   6 , Anne Marfaing-Koka  10 , Christophe Willekens  1 , Eric Deconinck  11 , David Ghez  1   12
Affiliations

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm

Sabine Khalife-Hachem et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Figures

Figure 1.
Figure 1.
Response to treatment and outcome. Swimmer plot depicts response, duration of response, and survival. CRi, complete hematologic response with incomplete marrow recovery.
See this image and copyright information in PMC

References

    1. Laribi K, Baugier de Materre A, Sobh M, et al. Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients. Blood Adv. 2020;4(19):4838–4848. - PMC - PubMed
    1. Roos-Weil D, Dietrich S, Boumendil A, et al. European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood. 2013;121(3):440–446. - PubMed
    1. Guru Murthy G, Pemmaraju N, Attalah E. Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm. Leuk Research. 2018;73:21–23. - PubMed
    1. Khwaja R, Daly A, Wong M, Mahé E, Cerquozzi S, Owen C. Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases. Leuk Lymphoma. 2016;57(11):2720–2722. - PubMed
    1. Gangat N, Konopleva M, Patnaik MM, et al. Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm. Am J Hematol. 2022;97(2):E62–E67. - PubMed